MTF announces release of newly patented demineralized bone matrix allograft tissue product.
Demineralized bone matrices have been used as void fillers in musculoskeletal surgery for many years, and the market in the US for these DBM tissue forms is estimated to exceed $125 million annually. MTF says it will continue to distribute its Grafton Demineralized Bone Matrix, which is processed by Osteotech, Inc., Eatontown, NJ.
Synthes of Paoli, PA, has contracted with MTF to assist in educating clinicians about DBX.
Contact: Bruce Stroever - (732) 661-2200
|Printer friendly Cite/link Email Feedback|
|Comment:||MTF announces release of newly patented demineralized bone matrix allograft tissue product.|
|Article Type:||Brief Article|
|Date:||Oct 24, 2000|
|Previous Article:||Regeneration Technologies licenses exclusive rights to new demineralized bone technology.|
|Next Article:||Congress passes transplant legislation affecting OPOs, children; NOTA action on hold till next year.|